282 results on '"Bager, Peter"'
Search Results
2. A standardised protocol for assessment of relative SARS-CoV-2 variant severity, with application to severity risk for COVID-19 cases infected with Omicron BA.1 compared to Delta variants in six European countries
3. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study
4. A Danish questionnaire study of acute symptoms of SARS-CoV-2 infection by variant, vaccination status, sex and age
5. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark
6. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
7. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study
8. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
9. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark
10. Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study.
11. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
12. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible Enterococcus faecium: a nationwide cohort study in Denmark, 2010-2019.
13. Cohort profile:EFTER-COVID – a Danish nationwide cohort for assessing the long-term health effects of the COVID-19 pandemic
14. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible Enterococcus faecium:a nationwide cohort study in Denmark, 2010–2019
15. The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years:A national cohort study in Denmark
16. The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark
17. A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark.
18. Conflicting COVID-19 excess mortality estimates
19. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants:A population-based, matched cohort study
20. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant:a nation-wide population-based study in Denmark
21. Conflicting COVID-19 excess mortality estimates
22. Increased Risk of Inflammatory Bowel Disease in Families with Tonsillectomy: A Danish National Cohort Study
23. A hybrid register and questionnaire study of Covid-19 and post-acute sick leave in Denmark.
24. A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022.
25. Acute Symptoms of SARS-CoV-2 Infection by Variant, Vaccination Status, Sex and Age: A Questionnaire Study in Denmark
26. A Standardised Protocol for Assessment of Relative SARS-CoV-2 Variant Severity, with Application to Severity Risk for COVID-19 Cases Infected with Omicron BA.1 Compared to Delta Variants in six European Countries
27. The effectiveness of grass, birch, and mugwort pollen allergen immunotherapy over 18 years: A national cohort study in Denmark
28. Reply to correspondence: "The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark".
29. Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study
30. Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
31. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
32. Observed protection against SARS-CoV-2 reinfection following a primary infection:A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
33. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark:an observational cohort study
34. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
35. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
36. Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population
37. Cesarean Delivery and Risk of Intestinal Bacterial Infection
38. Self-Reported Adverse Events Following SARS-CoV-2 Vaccination: A Nationwide Questionnaire Study in the Adult Danish Population
39. Observed Protection Against SARS-CoV-2 Reinfection Following a Primary Infection: A Danish Cohort Study Using Two Years of Nationwide PCR-Test Data
40. Risk of Reinfection, Vaccine Protection, and Severity of Infection with the BA.5 Omicron Subvariant: A Danish Nation-Wide Population-Based Study
41. Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study
42. Filaggrin genotype and skin diseases independent of atopic dermatitis in childhood
43. Post–COVID-19 Condition Fatigue Outcomes Among Danish Residents.
44. Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
45. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury
46. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark:an observational cohort study
47. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury
48. Major stressful life events in adulthood and risk of multiple sclerosis
49. Tu1715 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ON EFFICACY AND SAFETY OF PROBIOTIC TREATMENT WITH TRICHURIS SUIS OVA IN PATIENTS WITH ULCERATIVE COLITIS
50. Interaction between filaggrin mutations and neonatal cat exposure in atopic dermatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.